Research Institutes

Transforming genetic data into actionable insights.

دعم الابتكار في السّلامة؛ لضمان تنمية مستدامة

Technology Transfer Office of Clalit Health Services

EnICS Labs Institute is a prominent semiconductor and integrated-circuits research center located within the Faculty of Engineering at Bar-Ilan University. Established in 2015 and designated as an institute in 2025, it is recognized as Israel's leading center for integrated-circuit design. The institute focuses on bridging academic research with industrial development through collaborative efforts led by a team of experienced faculty members. The institute offers a range of services, including joint industrial-academic R&D, hardware security research, chip and IC prototyping, and advanced measurement and validation. It is equipped with state-of-the-art tools and infrastructure, enabling research in various areas such as system-on-chip design, high-speed digital circuits, energy-efficient memory architectures, and hardware security innovations. EnICS Labs collaborates with over 30 companies and research groups globally, including a strategic partnership with Avnet ASIC in the EnICS-AVNET Innovation Center.

Fostering innovation and bridging research with industry.

Advancing drug innovations from research to market.

Research Products Development Company (RPDC), also known as RPD Innovations, is a national center for technology development and commercialization in Saudi Arabia. Established by the Saudi Arabia Advanced Research Alliance (SAARA), RPDC aims to bridge the gap between research and commercial success, supporting the country's Vision 2030 goals for economic diversification and innovation. Headquartered in Riyadh, RPDC plays a vital role in fostering Saudi Arabia's innovation ecosystem. It translates academic and industrial research into practical technologies, promotes entrepreneurship, and supports technology-driven industries. The company offers a range of services, including applied R&D, technology assessment, intellectual property management, and capacity building through training and collaborations. RPDC also provides investment and co-funding opportunities for deep tech startups, enhancing the economic impact of publicly funded research and creating jobs in the technology sector.

Empowering communities through collaborative research.

The Centre for Research on Innovation and Science Policy (CRISP) is a non-profit research organization established in March 2004. It focuses on promoting policy-relevant research in innovation policy, particularly in agriculture and rural development. Founded by a coalition of science policy researchers, CRISP advocates for a holistic approach to innovation policy. CRISP hosts the Secretariat of the Agricultural Extension in South Asia (AESA) Network, which facilitates sharing, learning, and networking for effective extension and advisory services. The organization conducts research on various topics, including agricultural innovation systems, evaluation of extension services, gender dimensions in agricultural research, climate-adaptive innovation, and the use of ICTs in agriculture. Its work aims to enhance India's science and technology ecosystem and address challenges in agriculture and rural development, with a focus on South Asia.

Accelerating drug discovery and commercialization in immunology and cancer.

TRIUMF Innovations Inc. is the commercialization arm of TRIUMF, Canada's national particle accelerator centre. It connects advanced scientific research with business opportunities through industry partnerships, licensing, and the creation of spinoff companies. The company leverages TRIUMF's expertise in particle acceleration and its extensive cyclotron infrastructure to drive innovation in fields such as medical isotopes and radiopharmaceuticals. The company facilitates access to TRIUMF's resources for businesses, offering services like R&D collaborations, technology licensing, and support for spinoff companies. It also operates facilities for testing in radiation environments and develops Good Manufacturing Practices-compliant facilities for clinical trials. TRIUMF Innovations plays a key role in initiatives like the Canadian Medical Isotope Ecosystem, which aims to enhance the production and supply of high-demand isotopes. TRIUMF Innovations focuses on technologies such as Actinium-225 for cancer treatment and Technetium-99m for diagnostic imaging. It collaborates with various partners, including Telix Pharmaceuticals and GE Healthcare, to expand the production and application of these isotopes, contributing to global supply chains and advancing medical research.

Podporujeme technologii HE3DA.